1. Home
  2. ADAG vs ATLO Comparison

ADAG vs ATLO Comparison

Compare ADAG & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adagene Inc.

ADAG

Adagene Inc.

HOLD

Current Price

$3.64

Market Cap

254.4M

Sector

Health Care

ML Signal

HOLD

Logo Ames National Corporation

ATLO

Ames National Corporation

HOLD

Current Price

$30.12

Market Cap

269.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADAG
ATLO
Founded
2011
1903
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
254.4M
269.2M
IPO Year
2020
2001

Fundamental Metrics

Financial Performance
Metric
ADAG
ATLO
Price
$3.64
$30.12
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$8.25
N/A
AVG Volume (30 Days)
186.8K
66.4K
Earning Date
04-01-2026
04-24-2026
Dividend Yield
N/A
3.43%
EPS Growth
N/A
8.03
EPS
N/A
0.38
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$79.97
Revenue Growth
N/A
N/A
52 Week Low
$1.44
$16.94
52 Week High
$4.75
$30.92

Technical Indicators

Market Signals
Indicator
ADAG
ATLO
Relative Strength Index (RSI) 50.78 63.75
Support Level $3.29 $27.55
Resistance Level $4.09 N/A
Average True Range (ATR) 0.31 0.56
MACD 0.00 0.13
Stochastic Oscillator 39.47 65.56

Price Performance

Historical Comparison
ADAG
ATLO

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

About ATLO Ames National Corporation

Ames National Corporation is a bank holding company based in the United States. Through its subsidiaries, it provides a range of banking and other financial products and services to customers in Iowa, mainly in Boone, Clarke, Hancock, Marshall, Polk, Story, Taylor, and Union in central, north-central, and south-central Iowa. The Group offers several financial products and services, including checking and savings accounts, time deposits, commercial, construction, and agricultural loans, personal loans, lines of credit, cash management services, merchant credit card processing, safe deposit boxes, and ATM services, among others. It caters to the banking needs of a diverse range of customers, including individuals, businesses, professionals, and enterprises.

Share on Social Networks: